146
Participants
Start Date
February 29, 2008
Primary Completion Date
September 30, 2009
Study Completion Date
September 30, 2009
insulin detemir
Treat-to-target dose titration scheme (individually adjusted), injection s.c. (under the skin), once or twice daily.
insulin aspart
Treat-to target dose titration scheme (individually adjusted), injection s.c. (under the skin), at larger meals.
Novo Nordisk Investigational Site, Skopje
Novo Nordisk Investigational Site, Budapest
Novo Nordisk Investigational Site, Sofia
Novo Nordisk Investigational Site, Glostrup Municipality
Novo Nordisk Investigational Site, Miskolc
Novo Nordisk Investigational Site, Odense
Novo Nordisk Investigational Site, Pleven
Novo Nordisk Investigational Site, Kolding
Novo Nordisk Investigational Site, Varna
Novo Nordisk Investigational Site, Prague
Novo Nordisk Investigational Site, Turku
Novo Nordisk Investigational Site, Toulouse
Novo Nordisk Investigational Site, Istanbul
Novo Nordisk Investigational Site, Altunizade-Istanbul
Novo Nordisk Investigational Site, Izmir
Novo Nordisk Investigational Site, Pardubice
Novo Nordisk Investigational Site, Seinäjoki
Novo Nordisk Investigational Site, Paris
Novo Nordisk Investigational Site, Olomouc
Novo Nordisk Investigational Site, Oulu
Novo Nordisk Investigational Site, Moscow
Novo Nordisk Investigational Site, Moscow
Novo Nordisk Investigational Site, Moscow
Novo Nordisk Investigational Site, Saint Petersburg
Novo Nordisk Investigational Site, Helsinki
Novo Nordisk Investigational Site, Gdansk
Novo Nordisk Investigational Site, Kielce
Novo Nordisk Investigational Site, Warsaw
Novo Nordisk Investigational Site, Antalya
Novo Nordisk Investigational Site, Aberdeen
Novo Nordisk Investigational Site, Dundee
Novo Nordisk Investigational Site, Norfolk
Lead Sponsor
Novo Nordisk A/S
INDUSTRY